Anzeige
Mehr »
Montag, 29.09.2025 - Börsentäglich über 12.000 News
Seltene Ausgangslage: Unbekannter Kupfer-Explorer mit spekulativem Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41C58 | ISIN: CA09076M2004 | Ticker-Symbol: 5LB0
Frankfurt
29.09.25 | 15:52
0,187 Euro
+33,33 % +0,047
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOVAXYS TECHNOLOGY CORP Chart 1 Jahr
5-Tage-Chart
BIOVAXYS TECHNOLOGY CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,1520,18717:14

Aktuelle News zur BIOVAXYS TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:06BioVaxys Technology Corp.: BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")134The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets VANCOUVER, BC, Sept. 29, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB)...
► Artikel lesen
16.09.Biovaxys Technology Corp (2): Biovaxys closes $335,670 debenture offering12
16.09.BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING181// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:...
► Artikel lesen
11.09.XFRA NEW INSTRUMENTS AVAILABLE ON 11.09.2025240The following instruments on XETRA do have their first trading 11.09.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.09.2025 Aktien 1 US36318L2034 Galaxy Entertainment...
► Artikel lesen
10.09.Stocks in Play: BioVaxys Technology Corp17
10.09.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.09.2025356The following instruments on Boerse Frankfurt do have their last trading day on 10.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.09.2025ISIN NameCA09076M1014 BIOVAXYS...
► Artikel lesen
10.09.XFRA ISIN CHANGE311Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA09076M1014 BioVaxys Technology Corp. 10.09.2025 CA09076M2004 BioVaxys Technology Corp. 11.09.2025 Tausch 10:1
► Artikel lesen
09.09.Biovaxys Technology Corp (1): Biovaxys Technology 1:10 rollback6
BIOVAXYS TECHNOLOGY Aktie jetzt für 0€ handeln
09.09.CSE Bulletin: Consolidation - BioVaxys Technology Corp. (BIOV)293Toronto, Ontario--(Newsfile Corp. - Le 9 septembre/September 2025) - BioVaxys Technology Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated...
► Artikel lesen
08.09.Biovaxys Technology Corp: Biovaxys expects to complete 1:10 rollback Sept. 1111
05.09.BioVaxys announces share consolidation5
05.09.BioVaxys Technology Corp.: Biovaxys Announces Share Consolidation158VANCOUVER, BC, Sept. 5, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces, further...
► Artikel lesen
28.08.BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES UNSECURED CONVERTIBLE DEBENTURE OFFERING AND CANCELLATION OF BROKERED LIFE OFFERING485// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Aug. 27, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV)...
► Artikel lesen
16.07.Biovaxys Technology Corp: Biovaxys arranges minimum $2-million private placement20
16.07.BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE644// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV)...
► Artikel lesen
08.07.Biovaxys Technology Corp: Biovaxys hires Enclave Capital as agent for placement14
07.07.BioVaxys Technology Corp.: BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING368// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV)...
► Artikel lesen
20.06.Biovaxys Technology Corp: Biovaxys amends LIFE offering7
20.06.BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING405// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV)...
► Artikel lesen
04.06.BioVaxys Issues Corporate Update12
Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1